SCHEMBL7751891

SCHEMBL7751891

Cc1ccc(S(=O)(=O)OC2(c3ccccc3)CCNCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.41
HTR6 P50406 3/20 0.41
CYP2C19 P33261 1/20 0.40
VDR P11473 1/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
TACR1 P25103 1/20 0.38
ALDH1A1 P00352 2/20 0.37
GAA P10253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP10 P09238 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
STAT3 P40763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852373 0.79 OPRM1 (0.46) OPRM1HTR6CYP2C19VDRKMT2A
SCHEMBL974744 0.76 OPRM1 (0.59) OPRM1HTR6CYP2C19KMT2AMEN1
SCHEMBL24944276 0.76 RECQL (0.47) OPRM1CYP2C19KMT2AMEN1ALDH1A1
SCHEMBL24944860 0.72 OPRM1 (0.47) OPRM1CYP2C19KMT2AMEN1SMN1; SMN2
SCHEMBL7751889 0.72 MEN1 (0.55) OPRM1CYP2C19KMT2AMEN1SMN1; SMN2
SCHEMBL378736 0.70 CYP2C19 (0.63) OPRM1CYP2C19KMT2AMEN1
SCHEMBL613551 0.70 OPRM1 (0.55) OPRM1TACR1
SCHEMBL2341926 0.70 SMN1; SMN2 (0.48) CYP2C19VDRKMT2ASMN1; SMN2HTT
SCHEMBL25916447 0.69 TDP1 (0.39) ALDH1A1GAA
SCHEMBL7751916 0.69 OPRM1 (0.56) OPRM1CYP2C19KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242637-B1 USED IN TREATMENT INVOLVING THE TACHYKININ SYSTEM, SUCH AS PAIN, ALLERGY AND INFLAMMATION, CIRCULATORY, GASTROINTESTINAL, NEUROLOGICAL, AND NEUROPSYCHIATRIC DISORDERS SANOFI-SYNTHELABO (FR) 2001-06-05 US disclosed
US-6011154-A Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present SANOFI (FR) 2000-01-04 US disclosed
US-5977359-A Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present SANOFI (FR) 1999-11-02 US disclosed
US-5869663-A INTERMEDIATES FOR NEUROKININ RECEPTOR ANTAGONISTS SANOFI (FR) 1999-02-09 US disclosed
US-5780466-A DISORDERS ASSOCIATED WITH EXCESS TACHYKININS AND ALL NEUROKININ-DEPENDENT DISORDERS; ANALGESICS; RESPIRATORY, GASTROINTESTINAL, UROGENTIAL, IMMUNE, CARDIOVASCULAR AND CNS DISORDERS SANOFI (FR) 1998-07-14 US disclosed
US-5641777-A NEUROKININ RECEPTOR ANTAGONIST SANOFI (FR) 1997-06-24 US disclosed